Ellen M. van der Aar

813 total citations
14 papers, 553 citations indexed

About

Ellen M. van der Aar is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Ellen M. van der Aar has authored 14 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Rheumatology. Recurrent topics in Ellen M. van der Aar's work include Glutathione Transferases and Polymorphisms (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Reproductive Health and Contraception (2 papers). Ellen M. van der Aar is often cited by papers focused on Glutathione Transferases and Polymorphisms (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Reproductive Health and Contraception (2 papers). Ellen M. van der Aar collaborates with scholars based in Netherlands, Belgium and Sweden. Ellen M. van der Aar's co-authors include Julie Desrivot, Sonia Dupont, Toby M. Maher, Paul Ford, Ann Fieuw, Wim Wuyts, René Galien, Luc Van Rompaey, L. Lepescheux and Christel Menet and has published in prestigious journals such as The Journal of Immunology, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Ellen M. van der Aar

14 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen M. van der Aar Netherlands 9 172 148 129 128 96 14 553
Katsuyoshi Kawana Japan 8 139 0.8× 125 0.8× 124 1.0× 33 0.3× 44 0.5× 11 519
Michael Rosenbach United States 9 374 2.2× 132 0.9× 159 1.2× 39 0.3× 61 0.6× 9 671
Chi-Chung Chan China 10 155 0.9× 151 1.0× 41 0.3× 126 1.0× 100 1.0× 24 414
Yvonne Sun United States 7 309 1.8× 141 1.0× 44 0.3× 106 0.8× 16 0.2× 7 631
C. Brindley United Kingdom 11 322 1.9× 79 0.5× 49 0.4× 37 0.3× 30 0.3× 14 523
Wei‐Hwa Lee Taiwan 11 209 1.2× 123 0.8× 22 0.2× 86 0.7× 40 0.4× 26 464
Hideo Tateishi Japan 13 261 1.5× 141 1.0× 21 0.2× 100 0.8× 36 0.4× 31 601
Long Ma China 11 221 1.3× 136 0.9× 50 0.4× 90 0.7× 15 0.2× 25 522
Sally Parker United Kingdom 8 163 0.9× 78 0.5× 162 1.3× 23 0.2× 154 1.6× 11 485

Countries citing papers authored by Ellen M. van der Aar

Since Specialization
Citations

This map shows the geographic impact of Ellen M. van der Aar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. van der Aar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. van der Aar more than expected).

Fields of papers citing papers by Ellen M. van der Aar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M. van der Aar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. van der Aar. The network helps show where Ellen M. van der Aar may publish in the future.

Co-authorship network of co-authors of Ellen M. van der Aar

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M. van der Aar. A scholar is included among the top collaborators of Ellen M. van der Aar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M. van der Aar. Ellen M. van der Aar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aar, Ellen M. van der, Julie Desrivot, David Amantini, et al.. (2018). ADAMTS-5 inhibitor GLPG1972, a potential new treatment in osteoarthritis, shows favorable safety, pharmacokinetics and pharmacodynamics in healthy subjects. Osteoarthritis and Cartilage. 26. S310–S310. 9 indexed citations
2.
Maher, Toby M., Ellen M. van der Aar, Julie Desrivot, et al.. (2018). Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. The Lancet Respiratory Medicine. 6(8). 627–635. 175 indexed citations
3.
4.
Menet, Christel, Stephen R. Fletcher, Guy Van Lommen, et al.. (2014). Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634. Journal of Medicinal Chemistry. 57(22). 9323–9342. 93 indexed citations
5.
Rompaey, Luc Van, René Galien, Ellen M. van der Aar, et al.. (2013). Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases. The Journal of Immunology. 191(7). 3568–3577. 181 indexed citations
6.
Aar, Ellen M. van der, et al.. (2000). Interaction profile and tolerability of barnidipine.. PubMed. 36–40. 5 indexed citations
7.
Aar, Ellen M. van der, et al.. (1998). Strategies to Characterize the Mechanisms of Action and the Active Sites of GlutathioneS-Transferases: A Review. Drug Metabolism Reviews. 30(3). 569–643. 10 indexed citations
8.
Aar, Ellen M. van der, et al.. (1997). 4-Substituted 1-Chloro-2-nitrobenzenes:  Structure−Activity Relationships and Extension of the Substrate Model of Rat Glutathione S-Transferase 4-4. Chemical Research in Toxicology. 10(4). 439–449. 8 indexed citations
9.
10.
Aar, Ellen M. van der, Jan N. M. Commandeur, J.M. te Koppele, et al.. (1996). Enzyme kinetics and substrate selectivities of rat glutathione S-transferase isoenzymes towards a series of new 2-substituted 1-chloro-4-nitrobenzenes. Xenobiotica. 26(2). 143–155. 17 indexed citations
11.
Aar, Ellen M. van der, et al.. (1996). Structure−Activity Relationships for the Glutathione Conjugation of 2-Substituted 1-Chloro-4-nitrobenzenes by Rat Glutathione S-Transferase 4-4. Chemical Research in Toxicology. 9(2). 527–534. 8 indexed citations
12.
Groot, Marcel J. de, et al.. (1995). A Predictive Substrate Model for Rat Glutathione S-Transferase 4-4. Chemical Research in Toxicology. 8(5). 649–658. 8 indexed citations
13.
Vliet, Albert van der, Ellen M. van der Aar, & Aalt Bast. (1991). The lipid peroxidation product 4-hydroxy-2,3-trans-1 nonenal decreases rat intestinal smooth muscle function in-vitro by alkylation of sulphydryl groups. Journal of Pharmacy and Pharmacology. 43(7). 515–517. 8 indexed citations
14.
Sterk, Geert Jan, et al.. (1991). 4- or 5-(ω-Aminoalkyl)Thiazoles and Derivatives; New Selective H2-Receptor Agonists. Birkhäuser Basel eBooks. 33. 301–314. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyoshi Kawana Breakdown of academic impact, for papers by Michael Rosenbach Breakdown of academic impact, for papers by Chi-Chung Chan Breakdown of academic impact, for papers by Yvonne Sun Breakdown of academic impact, for papers by C. Brindley Breakdown of academic impact, for papers by Wei‐Hwa Lee Breakdown of academic impact, for papers by Hideo Tateishi Breakdown of academic impact, for papers by Long Ma Breakdown of academic impact, for papers by Sally Parker
Rankless by CCL
2026